Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)
尼拉帕尼和多斯塔利单抗治疗复发性铂耐药卵巢癌:II期研究结果(MOONSTONE/GOG-3032)
期刊:Gynecologic Oncology
影响因子:4.1
doi:10.1016/j.ygyno.2023.10.005
Randall, Leslie M; O'Malley, David M; Monk, Bradley J; Coleman, Robert L; Gaillard, Stephanie; Adams, Sarah; Duska, Linda R; Dalton, Heather; Holloway, Robert W; Huang, Marilyn; Chon, Hye Sook; Cloven, Noelle G; ElNaggar, Adam C; O'Cearbhaill, Roisin E; Waggoner, Steven; Tarkar, Aarti; Striha, Alina; Nelsen, Linda M; Baines, Amanda; Samnotra, Vivek; Konstantinopoulos, Panagiotis A